*Please inquire the availability for this product. Anidulafungin is a semi-synthetic cyclic lipopeptide belonging to the echinocandin class that was reported in 1995 and commercially developed by Eli Lilly. Anidulafungin inhibits the synthesis of β-(1,3)-D-glucan, an essential component of the cell wall of susceptible fungi and is extensively referenced in the literature with over 400 citations.

Additional Information

Synonyms	LY 303366, Eraxis
Product #	A-2611
CAS #	166663-25-8
Chemical Name	N-(23-(1,2-DIHYDROXY-2-(4-HYDROXYPHENYL)ETHYL)-2,11,12,15-TETRAHYDROXY-6,20-BIS(1-HYDROXYETHYL)-16-METHYL-5,8,14,19,22,25-HEXAOXOTETRACOSAHYDRO-1H-DIPYRROLO[2,1-C:2',1'-L][1,4,7,10,13,16]HEXAAZACYCLOHENICOSIN-9-YL)-4''-(PENTYLOXY)-[1,1':4',1''-TERPHENYL]-
Formula	C58H73N7O17
MW	265.3
Appearance	White solid
Purity	>98% by HPLC
Storage Temp	-20° C
Therapeutic Area	Infectious Diseases
Use	Anisomycin is an antibiotic produced by Streptomyces griseolus bacteria

Additional Information

MDL Number	MFCD00077650
InChI	InChI=1S/C14H19NO4/c1-9(16)19-14-12(15-8-13(14)17)7-10-3-5-11(18-2)6-4-10/h3-6,12-15,17H,7-8H2,1-2H3/t12-,13+,14+/m0/s1
SMILES	CC(=O)O[C@H]1[C@@H](CN[C@H]1Cc2ccc(cc2)OC)O